Franco Trevisani - Publications

Alcohol Plays a Detrimental Role in the Prognosis of Hepatocellular Carcinoma Related to Steatotic Liver Disease.

Journal: Liver cancer

Published: November 11, 2025

Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: September 24, 2025

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.

Journal: Alimentary pharmacology & therapeutics

Published: September 10, 2025

The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and Diabetes.

Journal: Oncology research

Published: September 10, 2025

Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.

Journal: Digestive diseases and sciences

Published: March 02, 2025

Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 19, 2025

Outcome of hepatic resection for HCC in ideal and non-ideal candidates.

Journal: Hepatology communications

Published: January 26, 2025

Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison.

Journal: JHEP reports : innovation in hepatology

Published: November 19, 2024

Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma.

Journal: Hepatology international

Published: November 14, 2024

Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 24, 2024

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.

Journal: JAMA oncology

Published: July 18, 2024

DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.

Journal: Journal of viral hepatitis

Published: July 17, 2024